Vectibix 100mg Injection

Vectibix 100mg injection is an anticancer medicine in the class of epidermal growth factor receptor (EGFR) inhibitors. It contains panitumumab as the active ingredient and is used in patients with metastatic colorectal cancer (cancer originating in the colon or rectum that has spread to other parts of the body). Do not take this injection if you are allergic to any of its ingredients.

This drug works by targeting certain proteins in the body, which can increase the risk of bleeding. If you notice any signs of bleeding during treatment, such as unusual bleeding or bruising, black or tarry stools, blood in the urine, or bleeding gums, contact your doctor immediately. Your doctor may need to adjust your dose or temporarily stop treatment.

Eye problems can develop during treatment with this medicine, including inflammation and damage to the cornea. Symptoms may include eye pain, redness, blurred vision, and sensitivity to light. It is important to inform your doctor if you experience any skin problems while taking this medicine. Your doctor may recommend topical creams or ointments to soothe the skin or antibiotics to treat any infections that may develop.

Infusion reactions can occur as a side effect of this drug. These are allergic reactions that may happen during or shortly after the infusion of the medication. To reduce the risk of infusion reactions, your doctor will monitor you closely during and after the infusion and may give you medications such as antihistamines and corticosteroids to prevent or manage allergic reactions.

Vectibix 100mg injection is not recommended during pregnancy as it can harm the unborn baby. Inform your healthcare provider before starting this treatment if you are pregnant or planning to become pregnant. Both men and women should follow appropriate contraceptive methods during treatment and for 3 months after the last dose.

Metastatic colorectal cancer

Vectibix 100mg injection is a monoclonal antibody that attaches to a specific protein called epidermal growth factor receptor (EFGR) and induces the immune system’s fight against cancer. It interrupts the receptor signalling and thereby stops the cancer cells from spreading to other organs.

The medicine will be administered to you by a healthcare professional in a hospital setting. Vectibix 100mg injection is given as an injection into a vein (intravenous infusion) over a period of 60 minutes, every 14 days. Doses higher than 1000 mg should be administered over 90 minutes. The dose, route of administration, and frequency will be decided by your doctor based on your disease condition and other factors.

Side effects are unwanted symptoms caused by medicines. Even though all drugs cause side effects, not everyone gets them. Serious Acute Kidney failure Severe skin reactions Infusion-related reactions Swelling Severe diarrhea when used in combination treatment Lung problems Electrolyte imbalances Sensitivity to light Skin and eye disorders Dizziness Anxiety Common Anaemia Sleeplessness Decreased appetite Diarrhea, nausea, vomiting, or constipation Stomach pain Dry mouth Heartburn Tiredness Fever Headache Hair loss Back pain

This medicine can cause skin or tissue damage. Apply sunscreen or wear a hat before you travel outside, as sunlight can cause further skin damage. If your skin reaction is severe, contact your doctor right away. It is necessary to practice good hygiene, such as washing your hands frequently, avoiding close contact with sick individuals, and also avoiding sharing personal items such as towels or utensils. Women of childbearing age should discuss family planning with their doctor before starting treatment with Vectibix 100mg injection, as this medication may harm a developing fetus.